Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOrascom Inv Regulatory News (OIH)

  • This share is currently suspended. It was suspended at a price of 0.014

Share Price Information for Orascom Inv (OIH)

Share Price is delayed by 15 minutes
Get Live Data
0.014    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: $14.69m
OIH Live PriceLast checked at - London Stock Exchange

Intraday Orascom Inv Share Chart

  • This share is an international stock.

OIH BOD Minutes Summary

15 Nov 2021 08:20

RNS Number : 3709S
Orascom Investment Holding S.A.E
15 November 2021
 

Orascom Investment Holding S.A.E.

Established pursuant to the provisions of Law 95/1992

Head Office: Nile City Towers, South Tower,

2005 A corniche El Nile, Ramlet Beaulac, 11221, Cairo, Egypt

Authorized Capital: EGP 2,885,129,841 billion

Issued Capital: EGP 577,025,968.2 (fully paid)

Number of Issued Shares: 5,245,690,620

Commercial register number: 394061 Cairo

Summary of Board of Directors Resolutions

September 14, 2021

 

On the 12th of September 2021, pursuant to the invitation of Eng. Akil Hamed Beshir - Non-Executive Chairman, the following matters were discussed, and the following resolutions were taken by the Company's Board of Directors ("BoD"), namely:

- Eng. Akil Hamed Beshir, Non-executive Chairman (independent) and by proxy from Mr. Ashraf Abdel Tawab Salman, Non-Executive Expert Board Member (independent);

- Eng. Naguib Onsi Sawiris, CEO and Managing Director;

- Mr. Oussama Daniel Nassif, Executive Board Member;

- Mr. Mohamed Hamdan Ashmawy, Non-Executive Expert Board Member; and

- Mrs. Wafaa Shoukry Zaklama, Non-Executive Board Member.

The meeting quorum was accordingly met.

Also, attended the meeting via conference call:

- Mr. Hassan Mostafa Abdo, Non-Executive Board Member; and

- Eng. Iskandar Shalaby, Non-Executive Board Member.

 

- Ms. Nada Yasser Hafez - Secretary of the Board

The Resolutions:

First resolution: The Board unanimously approved the AC's report on the standalone and consolidated financial statements for the financial period from 01/01/2021 and ending on 30/09/2021.

 

Second resolution: The Board unanimously approved the Auditor's report on the standalone and consolidated financial statements for the financial period from 01/01/2021 and ending on 30/09/2021.

Third resolution: The Board unanimously approved the Board of Directors' report on the standalone and consolidated financial statements and business results for the period from 01/01/2021 and ending on 30/09/2021.

 

Fourth resolution: The Board unanimously ratified the standalone and consolidated financial statements and business results for the financial period from 01/01/2021 and ending on 30/09/2021.

 

Fifth resolution:  1. The board approved (with the abstention of the related board members Eng. Alexandre Shalaby and Mr. Oussama Daniel Nassif) to ratify the independent auditor's report on the IFA report on the fair value of Trans World Associates Private Limited, and the IFA report on the fair value of Trans World Associates Private Limited.

 

2. The Board extended the delegation given on 27/04/2021 to Eng. Naguib Onsi Sawiris and Mr. Oussama Daniel Nassif, severally, to sign all documents, contracts and papers required until the completion of the sale

 

Sixth resolution: The Board unanimously approved to add to the Company's signature matrix the following:

In addition to signatory powers in the commercial register, Eng. Naguib Onsi Naguib Sawiris, CEO and Managing Director and Mr. Oussama Daniel Nassif, Executive Board Member, shall have the right, severally, to establish new companies outside of Egypt and to sign all investments contracts, documents, papers, acknowledgments and issue powers of attorney related to all or part of the above, outside of Egypt.

 

 

 

Chief Financial Officer

Marwan Mohamed Hussein

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCDKPBDFBDKCDD
Date   Source Headline
22nd Apr 20263:12 pmRNSOIH Annual Financial Statements IFRS 2024
8th Apr 202611:01 amRNSAnnual Financial Report
29th Dec 20257:00 amRNSAnnual Financial Report
29th Dec 20257:00 amRNSAnnual Financial Report
24th Dec 20249:13 amRNSOIH BOD Summary - IFRS 2022
12th Dec 20249:36 amRNSOIH BOD Summary
19th Nov 20249:14 amRNSOIH Board Summary
30th Oct 20247:44 amRNSOrascom Investment Holding IFRS 2021
30th Oct 20247:43 amRNSOrascom Investment Holding BOD Meeting Summary
19th Aug 20247:00 amRNSOIH BOD Summary
4th Jul 202410:38 amRNSOIH BOD Summary
11th Jun 20248:48 amRNSOIH BOD Summary
28th May 20247:00 amRNSOIH OGM Summary
1st May 20249:56 amRNSOIH OGM Invitation Notice of Change
30th Apr 20248:46 amRNSOIH OGM Invitation
29th Apr 20247:00 amRNSOIH BOD Summary
18th Dec 20237:00 amRNSOIH BOD Summary
27th Nov 20237:00 amRNSOIH BOD Summary
15th Nov 20239:40 amRNSOIH BOD Summary
2nd Oct 202310:25 amRNSOIH Press Release
21st Sep 20238:09 amRNSOIH BOD Summary
31st Aug 202311:39 amRNSOIH BOD Summary
15th Aug 20238:29 amRNSOIH BOD Summary
19th Jun 20237:30 amRNSSuspension - Orascom Investment Holding S.A.E.
15th Jun 20239:17 amRNSOIH BOD Summary
1st Jun 20239:45 amRNSOIH BOD Summary
31st May 20239:47 amRNSOIH BOD Summary
16th May 20238:05 amRNSOIH BOD Summaries
16th May 20238:04 amRNSOIH OGM Summaries
9th May 20237:00 amRNSOIH Announces a Partnership with BluEV
2nd May 202312:06 pmRNSIFRS Dec 2020 including audit report
2nd May 20237:00 amRNSOGM Postponement Notice
27th Apr 20239:29 amRNSOIH IFRS December 2020
27th Apr 20239:27 amRNSOIH BOD Summary
12th Apr 20231:07 pmRNSOIH OGM Invitation
4th Apr 20239:44 amRNSOIH BOD Minutes Summaries
5th Dec 20228:20 amRNSOIH's BOD Summary
21st Nov 20224:41 pmRNSSecond Price Monitoring Extn
21st Nov 20224:35 pmRNSPrice Monitoring Extension
16th Nov 20229:42 amRNSOIH BOD Summary
26th Oct 20229:33 amRNSOIH Press Release
26th Oct 20228:58 amRNSOIH Press Release
26th Oct 20228:54 amRNSOIH BOD Summaries
18th Oct 202210:47 amRNSOIH BOD Summaries
16th Jun 20229:15 amRNSOIH Board Meeting Summary
9th May 20229:46 amRNSOIH OGM Summary
31st Mar 20229:45 amRNSOIH OGM Invitation
31st Mar 20229:37 amRNSOIH Board Meeting Summary
25th Feb 20224:41 pmRNSSecond Price Monitoring Extn
25th Feb 20224:36 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.